Announce Date | 08/06/2025 |
EPS Normalized Actual | $0.25 (Beat by $0.08) |
EPS GAAP Actual | $0.25 (Beat by $0.08) |
Revenue Actual | $0.288343B |
Revenue Surprise | Beat by $288.343M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.0605 |
EPS GAAP Estimate | $0.0605 |
Revenue Estimate | $0.22448785B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.0008 | 11.34 | 0.96453 | 1.04091 | 3 |
Dec 2028 | 0.3185 | 35.64 | 0.29121 | 0.34208 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.33 | 0.282147 | 0.288343B | 4.57% | 73.24M |
FQ1 2025 (Mar 2025) | 0.15 | 0.15 | 0.299499B | -1.3% | 299.5M |
FQ4 2024 (Dec 2024) | -0.26 | -0.26 | 0.302387B | -14.21% | 302.39M |
FQ3 2024 (Sep 2024) | 0.14 | 0.14 | 0.313422B | -9.72% | 313.42M |
FQ2 2024 (Jun 2024) | 0.18 | 0.18 | 0.275166B | 32.94% | 275.17M |
FQ1 2024 (Mar 2024) | 0.31 | 0.31 | 0.303398B | 25.34% | 303.4M |
FQ4 2023 (Dec 2023) | -0.14 | -0.14 | 0.345355B | 100% | 345.36M |
FQ3 2023 (Sep 2023) | 0.28 | 0.28 | 0.343893B | 100% | 343.89M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.0605
Consensus Revenue Estimates
0.22448785B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.06105 | -- | 0.05946708 | 0.06263292 | 1 |
FQ3 2027 (Sep 2027) | 0.2028 | -- | 0.2028 | 0.2028 | 1 |
FQ2 2027 (Jun 2027) | 0.1661 | -- | 0.1661 | 0.1661 | 1 |
FQ1 2027 (Mar 2027) | 0.11125 | -- | 0.10837 | 0.11413 | 1 |
FQ4 2026 (Oct 2026) | 0.04765 | -- | 0.04765 | 0.04765 | 0 |
FQ3 2026 (Jul 2026) | 0.06215 | -- | 0.06215 | 0.06215 | 0 |
FQ2 2026 (Jun 2026) | 0.062485 | -428.13 | 0.062485 | 0.062485 | 0 |
FQ1 2026 (Mar 2026) | 0.061377 | -144.39 | 0.061377 | 0.061377 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.48B | -- | 0.47B | 0.49B | 1 |
FQ3 2027 (Sep 2027) | 0.52B | -- | 0.52B | 0.52B | 1 |
FQ2 2027 (Jun 2027) | 0.41B | -- | 0.41B | 0.41B | 1 |
FQ1 2027 (Mar 2027) | 0.4B | -- | 0.39B | 0.41B | 1 |
FQ4 2026 (Oct 2026) | 0.22B | -- | 0.22B | 0.22B | 0 |
FQ3 2026 (Jul 2026) | 0.22B | -- | 0.22B | 0.22B | 0 |
FQ2 2026 (Jun 2026) | 1.21B | 76.15 | 1.21B | 1.21B | 0 |
FQ1 2026 (Mar 2026) | 1.12B | 73.32 | 1.12B | 1.12B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.047853 | 0.33 | 0.282147 | 85.5% |
FQ1 2025 (Mar 2025) | 0.15 | 0.15 | 100% | |
FQ4 2024 (Dec 2024) | -0.26 | -0.26 | 100% | |
FQ3 2024 (Sep 2024) | 0.14 | 0.14 | 100% | |
FQ2 2024 (Jun 2024) | 0.18 | 0.18 | 100% | |
FQ1 2024 (Mar 2024) | 0.31 | 0.31 | 100% | |
FQ4 2023 (Dec 2023) | -0.14 | -0.14 | 100% | |
FQ3 2023 (Sep 2023) | 0.28 | 0.28 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.22B | $0.29B | $73.24M | 25.4% |
FQ1 2025 (Mar 2025) | $0B | $0.3B | $299.5M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.3B | $302.39M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.31B | $313.42M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.28B | $275.17M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.3B | $303.4M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.35B | $345.36M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.34B | $343.89M | 100% |